Christoph Schröder

Title: Christoph Schröder: Innovator in Cancer Diagnosis and Prediction

Introduction

Christoph Schröder is a prominent inventor based in Heidelberg, Germany. He has made significant contributions to the field of cancer diagnosis and prediction, holding a total of four patents. His work focuses on innovative methods that enhance the accuracy of cancer detection and treatment.

Latest Patents

One of Christoph Schröder's latest patents is titled "Means and methods for diagnosing pancreatic cancer." This invention pertains to a method for diagnosing pancreatic cancer in a subject by determining the amount of specific biomarkers in a sample. The method involves comparing these biomarker levels with a reference to diagnose the presence of pancreatic cancer. Additionally, it includes a method for identifying subjects in need of pancreatic cancer therapy based on the diagnosis. The invention also encompasses diagnostic devices and kits for implementing these methods.

Another significant patent is "Prediction of recurrence for bladder cancer by a protein signature in tissue samples." This invention relates to predicting the risk of bladder cancer recurrence after treatment. It involves determining the levels of specific biomarkers and comparing them to reference amounts to assess the risk of recurrence. This patent also includes methods for identifying subjects who may require further bladder cancer therapy, along with diagnostic devices and kits for these methods.

Career Highlights

Throughout his career, Christoph Schröder has worked with esteemed institutions such as the Deutsches Krebsforschungszentrum and the University of London. His experience in these organizations has contributed to his expertise in cancer research and diagnostics.

Collaborations

Christoph has collaborated with notable colleagues, including Jörg Hoheisel and Tatjana Crnogorac-Jurcevic. These collaborations have further enriched his research and innovations in the field of cancer diagnosis.

Conclusion

Christoph Schröder is a dedicated inventor whose work in cancer diagnosis and prediction has the potential to significantly impact patient care. His innovative patents reflect his commitment to advancing medical technology and improving outcomes for cancer patients.